NASDAQ: RXRXRecursion Pharmaceuticals Inc Stock Ownership - Who owns Recursion Pharmaceuticals?
Insider buying vs selling
Have Recursion Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Michael Secora | Chief Financial Officer | 2024-04-17 | 23,124 | $7.58 | $175.35kSell |
| Michael Secora | Chief Financial Officer | 2024-04-17 | 37,500 | $2.22 | $83.25kBuy |
| Michael Secora | Chief Financial Officer | 2024-04-16 | 25,000 | $7.67 | $191.65kSell |
| Michael Secora | Chief Financial Officer | 2024-04-16 | 37,500 | $2.22 | $83.25kBuy |
| Blake Borgeson | Director | 2024-04-16 | 11,447 | $7.66 | $87.73kSell |
| Christopher Gibson | Chief Executive Officer | 2024-04-04 | 40,000 | $9.02 | $360.80kSell |
| Christopher Gibson | Chief Executive Officer | 2024-04-04 | 25,000 | $9.02 | $225.50kSell |
| Christopher Gibson | Chief Executive Officer | 2024-04-03 | 40,000 | $8.84 | $353.60kSell |
| Christopher Gibson | Chief Executive Officer | 2024-04-03 | 25,000 | $8.84 | $221.00kSell |
| Blake Borgeson | Director | 2024-04-02 | 11,447 | $8.82 | $100.94kSell |
RXRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when RXRX insiders and whales buy or sell their stock.
RXRX Shareholders
What type of owners hold Recursion Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Lux Ventures Iv LP | 12.92% | 30,308,614 | $246.11M | Insider |
| Baillie Gifford Co | 10.30% | 24,179,504 | $196.34M | Institution |
| Ark Investment Management LLC | 8.80% | 20,654,287 | $167.71M | Institution |
| Vanguard Group Inc | 6.68% | 15,665,210 | $127.20M | Institution |
| Mubadala Investment Co Pjsc | 5.53% | 12,985,927 | $105.45M | Institution |
| Blackrock Inc | 5.28% | 12,393,872 | $100.64M | Institution |
| State Street Corp | 5.18% | 12,151,646 | $98.67M | Institution |
| Fmr LLC | 4.64% | 10,897,287 | $88.49M | Institution |
| Kinnevik Ab Publ | 4.43% | 10,405,668 | $84.49M | Institution |
| Nikko Asset Management Americas Inc | 3.92% | 9,203,780 | $74.73M | Institution |
RXRX vs Biotech Stocks
Recursion Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.